Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer-Reference-Cited by-同舟云学术

Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer

Published:2017-09-15 Issue:2 Volume:194 Page:116-124
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Haefner Matthias Felix^ORCID,Lang Kristin,Verma Vivek,Koerber Stefan Alexander,Uhlmann Lorenz,Debus Juergen,Sterzing Florian

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/article/10.1007/s00066-017-1211-0/fulltext.html

Reference31 articles.

1. National Comprehensive Cancer Network (2016) Clinical practice guidelines in oncology—esophageal and esophagogastric junction cancers. https://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp . Accessed 20 Sept 2016

2. van Hagen P, Hulshof MCCM, van Lanschot JJB et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(20):2074–2084

3. Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12(7):681–692

4. Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23(10):2310–2317

5. Bedenne L, Michel P, Bouché O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25(10):1160–1168

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of esophageal cancer survival after neoadjuvant chemoradiotherapy plus surgery versus definitive chemoradiotherapy: A systematic review and meta-analysis;Asian Journal of Surgery;2024-09

2. A Comprehensive Benchmark of Transcriptomic Biomarkers for Immune Checkpoint Blockades;Cancers;2023-08-14

3. Survival Outcomes of Patients with Esophageal Cancer Who Did Not Proceed to Surgery after Neoadjuvant Treatment;Cancers;2023-08-10

4. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1;Esophagus;2023-03-18

5. The Role of Age and Comorbidities in Esophagogastric Cancer Chemoradiation of the Frail Elderly (>70 Years): An Analysis from a Tertiary High Volume-Center;Cancers;2022-12-23